Dose Escalation Study of Intravitreal 4D-110 in Patients With Choroideremia
Dose Escalation Study of Intravitreal 4D-110 in Patients With Choroideremia
Active, not recruiting · NCT04483440 · Registry updated 2025-05-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dose Escalation Study of Intravitreal 4D-110 in Patients With Choroideremia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, X-linked disease, choroideremia, eye disorder, hereditary disease, optic choroid disorder, uveal disorder | Active, not recruiting | Phase 1 | 2025-05-22 | NCT04483440 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| 4D Molecular Therapeutics | 10 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Moran Eye Center, University of Utah | Salt Lake City | United States | 1 |
| Retina Foundation of the Southwest | Dallas | United States | 1 |